The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
ConditionIgA Nephropathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorRuijin Hospital
About this trial
1. Establish an IgAN cohort collaboration group and expert committee to carry out registration research. 2. Construct IgAN structured data set standards, formulate structured data collection templates of diagnosis and treatment , and establish multi-center data integration systems on this basis. 3. Establish a standardized IgAN database for combined Hospital Information System and the big data platform of the Medical Federation. 4. Develop IgAN database managements and open standards for data sharing, and carry out high-quality clinical or basic research.
Eligibility criteria
Qualifiers
No age limit, no gender limit;
Kidney biopsy confirmed primary IgA nephropathy;
Sign the informed consent form voluntarily
Disqualifiers
IgA nephropathy is secondary to systemic diseases such as systemic lupus erythematosus and allergic purpura;
IgAN is clinically diagnosed but not confirmed by pathology;
The patient refuses to participate;
Patients judged by other investigators to be unsuitable for inclusion in the study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Ruijin Hospital
Lead sponsor
RenJi Hospital
Collaborator
Huashan Hospital
Collaborator
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Collaborator
Source ClinicalTrials.gov